Charles Prince Zuta is a notable inventor based in Maple Valley, WA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Zuta holds 2 patents, with his latest invention focusing on an optically active PDE10 inhibitor. This invention is directed to a pure enantiomer of 1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone, specifically the compound (S)-1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone. The invention also includes a crystal structure of this compound, a pharmaceutical composition, and methods for inhibiting PDE10 using this specific enantiomer.

Career Highlights

Zuta is currently associated with Omeros Corporation, where he continues to advance his research and development efforts in the pharmaceutical sector. His work has been instrumental in creating innovative solutions that address various medical needs.

Collaborations

Some of his notable coworkers include Neil S Cutshall and Kenneth M Ferguson, who have collaborated with him on various projects within the company.

Conclusion

Charles Prince Zuta's contributions to pharmaceutical chemistry through his patents and work at Omeros Corporation highlight his role as an influential inventor in the industry. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.